UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Diagnosis and treatment of basal cell carcinoma: European consensus–based interdisciplinary guidelines

European journal of cancer (1990), 2019-09, Vol.118, p.10-34

2019

Volltextzugriff (PDF)

Melanoma epidemiology and trends

Clinics in dermatology, 2009, Vol.27 (1), p.3-9

2009

Volltextzugriff (PDF)

Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline – Update 2016

European journal of cancer (1990), 2016-08, Vol.63, p.201-217

2016

Volltextzugriff (PDF)

Epidemiology of cutaneous melanoma and keratinocyte cancer in white populations 1943–2036

European journal of cancer (1990), 2021-07, Vol.152, p.18-25

2021

Volltextzugriff (PDF)

Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline

European journal of cancer (1990), 2015-09, Vol.51 (14), p.1989-2007

2015

Volltextzugriff (PDF)

Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study

BMC cancer, 2017-05, Vol.17 (1), p.332-332, Article 332

2017

Volltextzugriff (PDF)

European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics – Update 2019

European journal of cancer (1990), 2020-02, Vol.126, p.141-158

2020

Volltextzugriff (PDF)

Phase II DeCOG-study of ipilimumab in pretreated and treatment-naïve patients with metastatic uveal melanoma

PloS one, 2015-03, Vol.10 (3), p.e0118564

2015

Volltextzugriff (PDF)

Phase III Randomized Clinical Trial Comparing Tremelimumab With Standard-of-Care Chemotherapy in Patients With Advanced Melanoma

Journal of clinical oncology, 2013-02, Vol.31 (5), p.616-622

2013

Volltextzugriff (PDF)

Immune Checkpoint Blockade in Advanced Cutaneous Squamous Cell Carcinoma: What Do We Currently Know in 2020?

International journal of molecular sciences, 2020-12, Vol.21 (23), p.9300

2020

Volltextzugriff (PDF)

Disulfiram as a Therapeutic Agent for Metastatic Malignant Melanoma-Old Myth or New Logos?

Cancers, 2020-11, Vol.12 (12), p.3538

2020

Volltextzugriff (PDF)

Diagnosis and treatment of dermatofibrosarcoma protuberans. European consensus-based interdisciplinary guideline

European journal of cancer (1990), 2015-11, Vol.51 (17), p.2604-2608

2015

Volltextzugriff (PDF)

Improving melanoma classification by integrating genetic and morphologic features

PLoS medicine, 2008-06, Vol.5 (6), p.e120-e120

2008

Volltextzugriff (PDF)

The many unanswered questions related to the German skin cancer screening programme

European journal of cancer (1990), 2016-09, Vol.64, p.83-88

2016

Volltextzugriff (PDF)

Final Results of Phase III SYMMETRY Study: Randomized, Double-Blind Trial of Elesclomol Plus Paclitaxel Versus Paclitaxel Alone As Treatment for Chemotherapy-Naive Patients With Advanced Melanoma

Journal of clinical oncology, 2013-03, Vol.31 (9), p.1211-1218

2013

Volltextzugriff (PDF)

Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline

European journal of cancer (1990), 2010-01, Vol.46 (2), p.270-283

2010

Volltextzugriff (PDF)

Results of a Phase III, Randomized, Placebo-Controlled Study of Sorafenib in Combination With Carboplatin and Paclitaxel As Second-Line Treatment in Patients With Unresectable Stage III or Stage IV Melanoma

Journal of clinical oncology, 2009-06, Vol.27 (17), p.2823-2830

2009

Volltextzugriff (PDF)

Efficacy of PD-1–based immunotherapy after radiologic progression on targeted therapy in stage IV melanoma

European journal of cancer (1990), 2019-07, Vol.116, p.207-215

2019

Volltextzugriff (PDF)

Wnt-signaling enhances neural crest migration of melanoma cells and induces an invasive phenotype

Molecular cancer, 2018-02, Vol.17 (1), p.59-59, Article 59

2018

Volltextzugriff (PDF)

Epidemiology of Keratinocyte Skin Cancer with a Focus on Cutaneous Squamous Cell Carcinoma

Cancers, 2024-01, Vol.16 (3), p.606

2024

Volltextzugriff (PDF)

Targeting Rad51 as a strategy for the treatment of melanoma cells resistant to MAPK pathway inhibition

Cell death & disease, 2020-07, Vol.11 (7), p.581, Article 581

2020

Volltextzugriff (PDF)

Salicylsäurehaltige Rezepturen

Aktuelle Dermatologie, 2024-02, Vol.50 (1/02), p.87-90

2024

Volltextzugriff (PDF)

Antipsoriatika

Aktuelle Dermatologie, 2024-02, Vol.50 (1/02), p.84-86

2024

Volltextzugriff (PDF)

1 – 25 von 396

Suche als RSS-Feed

Aktive Filter

KollektionTaylor & Francis

KollektioneBooks on EBSCOhost

KollektionIngenta

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(374)
Mit Volltextzugriff
(305)

Publikationsform

Sprache

Englisch
(374)
Japanisch
(43)
Deutsch
(23)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Diagnosis and treatment of basal cell carcinoma: European consensus–based interdisciplinary guidelines

Melanoma epidemiology and trends

Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline – Update 2016

Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial

Epidemiology of cutaneous melanoma and keratinocyte cancer in white populations 1943–2036

Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline

Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study

European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics – Update 2019

Binimetinib versus dacarbazine in patients with advanced NRAS -mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial

Phase II DeCOG-study of ipilimumab in pretreated and treatment-naïve patients with metastatic uveal melanoma

Phase III Randomized Clinical Trial Comparing Tremelimumab With Standard-of-Care Chemotherapy in Patients With Advanced Melanoma

Immune Checkpoint Blockade in Advanced Cutaneous Squamous Cell Carcinoma: What Do We Currently Know in 2020?

Disulfiram as a Therapeutic Agent for Metastatic Malignant Melanoma-Old Myth or New Logos?

Diagnosis and treatment of dermatofibrosarcoma protuberans. European consensus-based interdisciplinary guideline

Improving melanoma classification by integrating genetic and morphologic features

The many unanswered questions related to the German skin cancer screening programme

Final Results of Phase III SYMMETRY Study: Randomized, Double-Blind Trial of Elesclomol Plus Paclitaxel Versus Paclitaxel Alone As Treatment for Chemotherapy-Naive Patients With Advanced Melanoma

Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline

Results of a Phase III, Randomized, Placebo-Controlled Study of Sorafenib in Combination With Carboplatin and Paclitaxel As Second-Line Treatment in Patients With Unresectable Stage III or Stage IV Melanoma

Efficacy of PD-1–based immunotherapy after radiologic progression on targeted therapy in stage IV melanoma

Wnt-signaling enhances neural crest migration of melanoma cells and induces an invasive phenotype

Epidemiology of Keratinocyte Skin Cancer with a Focus on Cutaneous Squamous Cell Carcinoma

Targeting Rad51 as a strategy for the treatment of melanoma cells resistant to MAPK pathway inhibition

Salicylsäurehaltige Rezepturen

Antipsoriatika

Aktive Filter

Suchergebnisse filtern